ONTX DD (August 23, 2020)
- Price: 1.01
- O/S: 183,578,267
- Float: 181,999,360
- Cash: ~23M
- Tech: https://www.onconova.com/
- Next Catalysts
- https://investor.onconova.com/news-releases/news-release-details/onconova-therapeutics-highlights-corporate-progress-and-reports
- Announcement of topline INSPIRE results by the end of the third quarter of 2020, with data presentation at a major medical meeting later in the year
- FDA review of Phase 2/3 trial protocol of oral rigosertib plus azacitidine in hypomethylating agent (HMA) naïve HR-MDS
- Federal funding agencies review of applications for clinical trials with rigosertib in SARS-COV-2 disease
- Virtual presentation at the 2nd Annual RAS-Targeted Drug Development Summit September 14-16, 2020
- Risk: Only thing I don’t like about ONTX is that they like dropping those offerings.
Onconova Therapeutics - ONTX
| Total Followers: | 0 |
|
|
|
| Follow | |